NFKB1 and cancer: Additional studies show similar inhibitory effects on NF‐κB and MAPK pathways in cancer and colitis models (Choo et al. 2011; Contant et al. 2021), as well as protection against TNF‐induced apoptosis through suppression of NF‐κB activation (Chainy et al. 2000).